Interestingly, both AKT3 and CDKN1B are linked to clinical head size syndromes and cancer risk17,18,19,20 and contain, respectively, 3′-UTR variants and an exonic variant that reach genome-wide significance. This evidence concerns the gene CDKN1B and cancer.